Liver cell-targeted delivery of therapeutic molecules

References

• Adrian JE, Kamps JA, Scherphof GL, et al. (2007). A novel lipid-based drug carrier targeted to the non-parenchymal cells, including hepatic stellate cells, in the fibrotic livers of bile duct ligated rates. Biochim Biophys Acta, 1768, 1430–9
   PubMed Web of Science ®Google Scholar
• Aggarwal P, Hall JB, McLeland CB, et al. (2009). Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev, 61, 428–37
   PubMed Web of Science ®Google Scholar
• Aina OH, Liu R, Sutcliffe JL, et al. (2007). From combinatorial chemistry to cancer-targeting peptides. Mol Pharmaceut, 4, 631–51
   PubMed Web of Science ®Google Scholar
• Altamirano J, Bataller R. (2011). Alcoholic liver disease: pathogenesis and new targets for therapy. Nat Rev Gastroenterol Hepatol, 8, 491–501
   PubMed Web of Science ®Google Scholar
• Altomonte J, Marozin S, Schmid RM, Ebert O. (2010). Engineered newcastle disease virus as an improved oncolytic agent against hepatocellular carcinoma. Mol Ther, 18, 275–84
   PubMed Web of Science ®Google Scholar
• Arima H, Yamashita S, Mori Y, et al. (2010). In vitro and in vivo gene delivery mediated by Lactosylated dendrimer/alpha-cyclodextrin conjugates (G2) into hepatocytes. J Control Release, 146, 106–17
   PubMed Web of Science ®Google Scholar
• Ashley CE, Carnes EC, Phillips GK, et al. (2011a). Cell-specific delivery of diverse cargos by bacteriophage MS2 virus-like particles. ACS Nano, 5, 5729–45
   PubMed Web of Science ®Google Scholar
• Ashley CE, Carnes EC, Phillips GK, et al. (2011b). The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers. Nat Mater, 10, 389–97
   PubMed Web of Science ®Google Scholar
• Bansal R, Prakash J, Ruijter M, et al. (2011). Peptide-modified albumin carrier explored as a novel strategy for a cell-specific delivery of interferon gamma to treat liver fibrosis. Mol Pharm, 8, 1899–909
   PubMed Web of Science ®Google Scholar
• Bareford LM, Swaan PW. (2007). Endocytic mechanisms for targeted drug delivery. Adv Drug Deliv Rev, 59, 748–58
   PubMed Web of Science ®Google Scholar
• Beljaars L, Olinga P, Molema G, et al. (2001). Characteristics of the hepatic stellate cell-selective carrier mannose 6-phosphate modified albumin (M6P(28)-HSA). Liver, 21, 320–8
   PubMedGoogle Scholar
• Biessen EA, Olinga P, Molema G, et al. (1994). Ligand size is a major determinant of high-affinity binding of fucose- and galactose-exposing (lipo)proteins by the hepatic fucose receptor. Biochem J, 299, 291–6
   PubMed Web of Science ®Google Scholar
• Bijsterbosch MK, Donker W, van de Bilt H, et al. (1996). Quantitative analysis of the targeting of mannose-terminal glucocerebrosidase. Predominant uptake by liver endothelial cells. Eur J Biochem, 237, 344–9
   PubMedGoogle Scholar
• Blechacz B, Splinter PL, Greiner S, et al. (2006). Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinoma. Hepatology, 44, 1465–77
   PubMed Web of Science ®Google Scholar
• Bonner JC. (2004). Regulation of PDGF and its receptors in fibrotic disease. Cytokine Growth Factor Rev, 15, 255–73
   PubMed Web of Science ®Google Scholar
• Bouchard MJ, Navas-Martin S. (2011). Hepatitis B and C virus hepatocarcinogenesis: lesions learned and future challenges. Cancer Lett, 305, 123–43
   PubMed Web of Science ®Google Scholar
• Cao H, Phan H, Yang LX. (2012). Improved chemotherapy for hepatocellular carcinoma. Anticancer Res, 32, 1379–86
   PubMed Web of Science ®Google Scholar
• Centelles MN, Isasi JR, Qian C, et al. (2010). Influence of the chitosan nature on the transfection efficacy of DNA-loaded nanoparticles after hydrodynamic administration in mice. J Microencapsul, 27, 460–9
   PubMed Web of Science ®Google Scholar
• Chandra PK, Kundu AK, Hazari S, et al. (2012). Inhibition of hepatitis C virus replication by intracellular delivery of multiple siRNAs by nanosomes. Mol Ther, 20, 1724–36
   PubMed Web of Science ®Google Scholar
• Chang ML, Chen JC, Yeh CT, et al. (2008). Gene gun bombardment with DNA-coated gold particles is a potential alternative to hydrodynamics-based transfection for delivering genes into superficial hepatocytes. Hum Gene Ther, 19, 391–5
   PubMed Web of Science ®Google Scholar
• Chaubey P, Mishra B. (2014). Mannose-conjugated chitosan nanoparticles loaded with rifampicin for the treatment of visceral leishmaniasis. Carbohydr Polym, 101, 1101–8
   PubMed Web of Science ®Google Scholar
• Cheng AL, Guan Z, Chen Z, et al. (2012). Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: subset analyses of the phase III Sorafenib Asia-Pacific trial. Eur J Cancer, 48, 1452–65
   PubMed Web of Science ®Google Scholar
• Chowdhury EH. 2009. Nuclear targeting of viral and non-viral DNA. Expert Opin Drug Deliv, 6, 697–703
   PubMed Web of Science ®Google Scholar
• Coulstock E, Sosabowski J, Ovečka M, et al. (2013). Liver-targeting of interferon-alpha with tissue-specific domain antibodies. PLoS One, 8, e57263
   PubMed Web of Science ®Google Scholar
• Cristiano RJ, Smith LC, Kay MA, et al. (1993). Hepatic gene therapy: efficient gene delivery and expression in primary hepatocytes utilizing a conjugated adenovirus-DNA complex. Proc Natl Acad Sci USA, 90, 11548–52
   PubMed Web of Science ®Google Scholar
• Daniels CK, Schmucker DL, Jones AL. (1989). Hepatic asialoglycoprotein receptor-mediated binding of human polymeric immunoglobulin A. Hepatology, 9, 229–34
   PubMed Web of Science ®Google Scholar
• Deng L, Li G, Xi L, et al. (2009). Hepatitis B virus inhibition in mice by lentiviral vector mediated short hairpin RNA. BMC Gastroenterol, 9, 73
   PubMed Web of Science ®Google Scholar
• Dini L, Autuori F, Lentini A, et al. (1992). The clearance of apoptotic cells in the liver is mediated by the asialoglycoprotein receptor. FEBS Lett, 296, 174–8
   PubMed Web of Science ®Google Scholar
• Dong L, Gao S, Diao H, et al. (2008). Galactosylated low molecular weight chitosan as a carrier delivering oligonucleotides to Kupffer cells instead of hepatocytes in vivo. J Biomed Mater Res A, 84, 777–84
   PubMed Web of Science ®Google Scholar
• Dong L, Zuo L, Xia S, et al. (2009). Reduction of liver tumor necrosis factor-α expression by targeting delivery of antisense oligonucleotides into Kupffer cells protects rats from fulminant hepatitis. J Gene Med, 11, 229–39
   PubMed Web of Science ®Google Scholar
• Du B, Han H, Wang Z, et al. (2010). Targeted drug delivery to hepatocarcinoma in vivo by phage-displayed specific binding peptide. Mol Cancer Res, 8, 135–44
   PubMed Web of Science ®Google Scholar
• Fabre JW, Grehan A, Whitehorne M, et al. (2008). Hydrodynamic gene delivery to the pig liver via an isolated segment of the inferior vena cava. Gene Ther, 15, 452–62
   PubMed Web of Science ®Google Scholar
• Fadden AJ, Holt OJ, Drickamer K. (2003). Molecular characterization of the rat Kupffer cell glycoprotein receptor. Glycobiology, 13, 529–37
   PubMed Web of Science ®Google Scholar
• Fichter M, Baier G, Dedters M, et al. (2013). Nanocapsules generated out of a polymeric dexamethasone shell suppress the inflammatory response of liver macrophages. Nanomedicine, 9, 1223–34
   PubMed Web of Science ®Google Scholar
• Fielding CJ. (1992). Lipoprotein receptors, plasma cholesterol metabolism, and the regulation of cellular free cholesterol concentration. FASEB J, 6, 3162–8
   PubMed Web of Science ®Google Scholar
• Finbloom DS, Magilavy DB, Harford JB, et al. (1981). Influence of antigen on immune complex behavior in mice. J Clin Invest, 68, 214–24
   PubMed Web of Science ®Google Scholar
• Fridman WH. (1991). Fc receptors and immunoglobulin binding factors. FASEB J, 5, 2684–90
   PubMed Web of Science ®Google Scholar
• Fu X, Rivera A, Tao L, et al. (2012). Construction of an oncolytic herpes simplex virus that precisely targets hepatocellular carcinoma cells. Mol Ther, 20, 339–46
   PubMed Web of Science ®Google Scholar
• Gallaher SD, Gil JS, Dorigo O, Berk AJ. (2009). Robust in vivo transduction of a genetically stable Epstein-Barr virus episome to hepatocytes in mice by a hybrid viral vector. J Virol, 83, 3249–57
   PubMed Web of Science ®Google Scholar
• Glebe D. (2007). Viral and cellular determinants involved in hepadnaviral entry. World J Gastroenterol, 13, 22–38
   PubMed Web of Science ®Google Scholar
• Haisma HJ, Bellu AR. (2011). Pharmacological interventions for improving adenovirus usage in gene therapy. Mol Pharm, 8, 50–5
   PubMed Web of Science ®Google Scholar
• Haisma HJ, Kamps JA, Kamps GK, et al. (2008). Polyinosinic acid enhances delivery of adenovirus vectors in vivo by preventing sequestration in liver macrophages. J Gen Virol, 89, 1097–105
   PubMed Web of Science ®Google Scholar
• Harris EN, Weigel JA, Weigel PH. (2008). The human hyaluronan receptor for endocytosis (HARE/Stabilin-2) is a systemic clearance receptor for heparin. J Biol Chem, 283, 17341–50
   PubMed Web of Science ®Google Scholar
• Hashida M, Nishikawa M, Yamashita F, Takakura Y. (2001). Cell specific delivery of genes with glycosylated carriers. Adv Drug Deliv Rev, 52, 187–96
   PubMed Web of Science ®Google Scholar
• Hattori Y, Koga K, Izumisawa T, et al. (2009). The distribution of mRNA expression and protein after hydrodynamic injection of transgene in mice. Biol Pharm Bull, 32, 755–9
   PubMed Web of Science ®Google Scholar
• Hayashi Y, Mori Y, Yamashita S, et al. (2012). Potential use of lactosylated dendrimer (G3)/α-cyclodextrin conjugates as hepatocyte-specific siRNA carriers for the treatment of familial amyloidotic polyneuropathy. Mol Pharm, 9, 1645–53
   PubMed Web of Science ®Google Scholar
• He Q, Lu WS, Liu Y, et al. (2013). 131I-labeled metuximab combined with chemoembolization for unresectable hepatocellular carcinoma. World J Gastroenterol, 19, 9104–10
   PubMed Web of Science ®Google Scholar
• Helmy KY, Katschke KJ Jr, Gorgani NN, et al. (2006). CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens. Cell, 124, 915–27
   PubMed Web of Science ®Google Scholar
• Herzer K, Sprinzl MF, Galle PR. (2007). Hepatitis viruses: live and let die. Liver Int, 27, 293–301
   PubMed Web of Science ®Google Scholar
• Higuchi Y, Nishikawa M, Kawakami S, et al. (2004). Uptake characteristics of mannosylated and fucosylated bovine serum albumin in primary cultured rat sinusoidal endothelial cells and Kupffer cells. Int J Pharm, 287, 147–54
   PubMed Web of Science ®Google Scholar
• Hirata K, Maruyama T, Watanabe H, et al. (2010). Genetically engineered mannosylated-human serum albumin as a versatile carrier for liver-selective therapeutics. J Control Release, 145, 9–16
   PubMed Web of Science ®Google Scholar
• Hisayasu S, Miyauchi M, Akiyama K, et al. (1999). In vivo targeted gene transfer into liver cells mediated by a novel galactosyl-D-lysine/D-serine copolymer. Gene Ther, 6, 689–93
   PubMed Web of Science ®Google Scholar
• Inamoto T, Brown WR. (1991). IgG is associated with the asialoglycoprotein receptor in the human liver. Hepatology, 14, 1070–5
   PubMed Web of Science ®Google Scholar
• Iobst ST, Drickamer K. (1996). Selective sugar binding to the carbohydrate recognition domains of the rat hepatic and macrophage asialoglycoprotein receptors. J Biol Chem, 271, 6686–93
   PubMed Web of Science ®Google Scholar
• Jacquier-Sarlin MR, Gabert FM, Villiers MB, Colomb MG. (1995). Modulation of antigen processing and presentation by covalently linked complement C3b fragment. Immunology, 84, 164–70
   PubMed Web of Science ®Google Scholar
• Jansen RW, Molema G, Ching TL, et al. (1991). Hepatic endocytosis of various types of mannose-terminated albumins. J Biol Chem, 266, 3343–8
   PubMed Web of Science ®Google Scholar
• Jemal A, Siegel R, Ward E, et al. (2007). Cancer statistics, 2007. CA Cancer J Clin, 57, 43–66
   PubMed Web of Science ®Google Scholar
• Jemal A, Siegel R, Ward E, et al. (2008). Cancer statistics, 2008. CA Cancer J Clin, 58, 71–96
   PubMed Web of Science ®Google Scholar
• Ji C, Sastry KS, Tiefenthaler G, et al. (2012). Targeted delivery of interferon-α to hepatitis B virus-infected cells using T-cell receptor-like antibodies. Hepatology, 56, 2027–38
   PubMed Web of Science ®Google Scholar
• Jia WD, Sun HC, Zhang JB, et al. (2007). A novel peptide that selectively binds highly metastatic hepatocellular carcinoma cell surface is related to invasion and metastasis. Cancer Lett, 247, 234–42
   PubMed Web of Science ®Google Scholar
• Jiang YQ, Wang HR, Li HP, et al. (2006). Targeting of hepatoma cell and suppression of tumor growth by a novel 12mer peptide fused to superantigen TSST-1. Mol Med, 12, 81–7
   PubMed Web of Science ®Google Scholar
• Jin H, Lovell JF, Chen J, et al. (2012). Mechanistic insights into LDL nanoparticle-mediated siRNA delivery. Bioconjug Chem, 23, 33–41
   PubMed Web of Science ®Google Scholar
• Johansson AG, Løvdal T, Magnusson KE, et al. (1996). Liver cell uptake and degradation of soluble immunoglobulin G immune complexes in vivo and in vitro in rats. Hepatology, 24, 169–75
   PubMed Web of Science ®Google Scholar
• Kamimura K, Suda T, Xu W, et al. (2009). Image-guided, lobe-specific hydrodynamic gene delivery to swine liver. Mol Ther, 17, 491–9
   PubMed Web of Science ®Google Scholar
• Kaneo Y, Tanaka T, Nakano T, Yamaguchi Y. (2001). Evidence for receptor-medicated hepatic uptake of pullulan in rats. J Control Release, 70, 365–73
   PubMed Web of Science ®Google Scholar
• Kang JH, Asai D, Kim JH, et al. (2008). Design of polymeric carriers for cancer-specific gene targeting: utilization of abnormal protein kinase Cα activation in cancer cells. J Am Chem Soc, 130, 14906–7
   PubMed Web of Science ®Google Scholar
• Kang JH, Mori T, Niidome T, Katayama Y. (2009). A syngeneic hepatocellular carcinoma model rapidly and simply prepared using a hydrodynamics-based procedure. Vet J, 181, 336–9
   PubMed Web of Science ®Google Scholar
• Kang JH, Oishi J, Kim JH, et al. (2010a). Hepatoma-targeted gene delivery using a tumor cell-specific gene regulation system combined with a human liver cell-specific bionanocapsule. Nanomedicine, 6, 583–9
   PubMed Web of Science ®Google Scholar
• Kang JH, Tachibana Y, Kamata W, et al. (2010b). Liver-targeted siRNA delivery by polyethylenimine (PEI)-pullulan carrier. Bioorg Med Chem, 18, 3946–50
   PubMed Web of Science ®Google Scholar
• Kang JH, Toita R, Katayama Y. (2010c). Bio and nanotechnological strategies for tumor-targeted gene therapy. Biotechnol Adv, 28, 757–63
   PubMed Web of Science ®Google Scholar
• Kang JH, Tachibana Y, Obika S, et al. (2012). Efficient reduction of serum cholesterol by combining a liver-targeted gene delivery system with chemically modified apolipoprotein B siRNA. J Control Release, 163, 119–24
   PubMed Web of Science ®Google Scholar
• Kawakami S, Sato A, Nishikawa M, et al. (2000). Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes. Gene Ther, 7, 292–9
   PubMed Web of Science ®Google Scholar
• Ketzinel-Gilad M, Zauberman A, Nussbaum O, et al. (2006). The use of the hydrodynamic HBV animal model to study HBV biology and anti-viral therapy. Hepatol Res, 34, 228–37
   PubMed Web of Science ®Google Scholar
• Khandare JJ, Minko T. (2006). Antibodies and peptides in cancer therapy. Crit Rev Ther Drug Carrier Syst, 23, 401–35
   PubMed Web of Science ®Google Scholar
• Kinoshita K, Iimuro Y, Fujimoto J, et al. (2007). Targeted and regulable expression of transgenes in hepatic stellate cells and myofibroblasts in culture and in vivo using an adenoviral Cre/loxP system to antagonize hepatic fibrosis. Gut, 56, 396–404
   PubMed Web of Science ®Google Scholar
• Kobayashi, N, Hirata K, Chen S, et al. (2004a). Hepatic delivery of particulates in the submicron range by a hydrodynamics-based procedure: implications for particulate gene delivery systems. J Gene Med, 6, 455–63
   PubMed Web of Science ®Google Scholar
• Kobayashi N, Nishikawa M, Hirata K, Takakura Y. (2004b). Hydrodynamics-based procedure involves transient hyperpermeability in the hepatic cellular membrane: implication of a nonspecific process in efficient intracellular gene delivery. J Gene Med, 6, 584–92
   PubMed Web of Science ®Google Scholar
• Kobayashi N, Kuramoto T, Yamaoka K, et al. (2001). Hepatic uptake and gene expression mechanisms following intravenous administration of plasmid DNA by conventional and hydrodynamics-based procedures. J Pharmacol Exp Ther, 297, 853–60
   PubMed Web of Science ®Google Scholar
• Kogelberg H, Tolner B, Sharma SK, et al. (2007). Clearance mechanism of a mannosylated antibody-enzyme fusion protein used in experimental cancer therapy. Glycobiology, 17, 36–45
   PubMed Web of Science ®Google Scholar
• Kosugi I, Muro H, Shirasawa H, Ito I. (1992). Endocytosis of soluble IgG immune complex and its transport to lysosomes in hepatic sinusoidal endothelial cells. J Hepatol, 16, 106–14
   PubMed Web of Science ®Google Scholar
• Kren BT, Unger GM, Sjeklocha L, et al. (2009). Nanocapsule-delivered Sleeping Beauty mediates therapeutic Factor VIII expression in liver sinusoidal endothelial cells of hemophilia A mice. J Clin Invest, 119, 2086–99
   PubMed Web of Science ®Google Scholar
• Kuiper J, Bakkeren HF, Biessen EA, Van Berkel TJ. (1994). Characterization of the interaction of galactose-exposing particles with rat Kupffer cells. Biochem J, 299, 285–90
   PubMed Web of Science ®Google Scholar
• Lehrman MA, Haltiwanger RS, Hill RL. (1986). The binding of fucose-containing glycoproteins by hepatic lectins. The binding specificity of the rat liver fucose lectin. J Biol Chem, 261, 7426–32
   PubMed Web of Science ®Google Scholar
• Leitinger B, Hohenester E. (2007). Mammalian collagen receptors. Matrix Biol, 26, 146–55
   PubMed Web of Science ®Google Scholar
• Li F, Li QH, Wang JY, et al. (2012). Effects of interferon-gamma liposomes targeted to platelet-derived growth factor receptor-beta on hepatic fibrosis in rats. J Control Release, 159, 261–70
   PubMed Web of Science ®Google Scholar
• Li FQ, Su H, Chen X, et al. (2009). Mannose 6-phosphate-modified bovine serum albumin nanoparticles for controlled and targeted delivery of sodium ferulate for treatment of hepatic fibrosis. J Pharm Pharmacol, 61, 1155–61
   PubMed Web of Science ®Google Scholar
• Liu F, Song Y, Liu D. (1999). Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther, 6, 1258–66
   PubMed Web of Science ®Google Scholar
• Liu S, McCormick KD, Zhao W, et al. (2012a). Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding. Hepatology, 56, 484–91
   PubMed Web of Science ®Google Scholar
• Liu X, Cao X, Wei R, et al. (2012b). Gene-viro-therapy targeting liver cancer by a dual-regulated oncolytic adenoviral vector harboring IL-24 and TRAIL. Cancer Gene Ther, 19, 49–57
   PubMed Web of Science ®Google Scholar
• Llovet JM, Ricci S, Mazzaferro V, et al. (2008). Sorafenib in advanced hepatocellular carcinoma. N Engl J Med, 359, 378–90
   PubMed Web of Science ®Google Scholar
• Lo A, Lin CT, Wu HC. (2008). Hepatocellular carcinoma cell-specific peptide ligand for targeted drug delivery. Mol Cancer Ther, 7, 579–89
   PubMed Web of Science ®Google Scholar
• Løvdal T, Andersen E, Brech A, Berg T. (2000). Fc receptor mediated endocytosis of small soluble immunoglobulin G immune complexes in Kupffer and endothelial cells from rat liver. J Cell Sci, 113, 3255–66
   PubMed Web of Science ®Google Scholar
• Lunov O, Syrovets T, Loos C, et al. (2011). Differential uptake of functionalized polystyrene nanoparticles by human macrophages and a monocytic cell line. ACS Nano, 5, 1657–69
   PubMed Web of Science ®Google Scholar
• Magnússon S, Berg T. (1993). Endocytosis of ricin by rat liver cells in vivo and in vitro is mainly mediated by mannose receptors on sinusoidal endothelial cells. Biochem J, 291, 749–55
   PubMed Web of Science ®Google Scholar
• Malik R, Selden C, Hodgson H. (2002). The role non-parenchymal cells in liver growth. Semin Cell Dev Biol, 13, 425–31
   PubMed Web of Science ®Google Scholar
• Malovic I, Sørensen KK, Elvevold KH, et al. (2007). The mannose receptor on murine liver sinusoidal endothelial cells is the main denatured collagen clearance receptor. Hepatology, 45, 1454–61
   PubMed Web of Science ®Google Scholar
• Managit C, Kawakami S, Yamashita F, Hashida M. (2005). Effect of galactose density on asialoglycoprotein receptor-mediated uptake of galactosylated liposomes. J Pharm Sci, 94, 2266–75
   PubMed Web of Science ®Google Scholar
• Manno CS, Pierce GF, Arruda VR, et al. (2006). Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat Med, 12, 342–7
   PubMed Web of Science ®Google Scholar
• Matsumura T, Hu Z, Kato T, et al. (2009). Amphipathic DNA polymers inhibit hepatitis C virus infection by blocking viral entry. Gastroenterology, 137, 673–81
   PubMed Web of Science ®Google Scholar
• Maximov VD, Reuko VV, Barry JN, et al. (2010). Protein-nanoparticle conjugates as potential therapeutic agents for the treatment of hyperlipidemia. Nanotechnology, 21, 265103
   PubMed Web of Science ®Google Scholar
• Melgert BN, Weert B, Schellekens H, et al. (2003). The pharmacokinetic and biological activity profile of dexamethasone targeted to sinusoidal endothelial and Kupffer cells. J Drug Target, 11, 1–10
   PubMed Web of Science ®Google Scholar
• Meng L, Yang L, Zhao X, et al. (2012). Targeted delivery of chemotherapy agents using a liver cancer-specific aptamer. PLoS ONE, 7, e33434
   PubMed Web of Science ®Google Scholar
• Mochizuki S, Morishita H, Sakurai K. (2013). Macrophage specific delivery of TNF-α siRNA complexed with β-1,3-glucan inhibits LPS-induced cytokine production in a murine acute hepatitis model. Bioorg Med Chem, 21, 2535–42
   PubMed Web of Science ®Google Scholar
• Morimoto K, Nishikawa M, Kawakami S, et al. (2003). Molecular weight-dependent gene transfection activity of unmodified and galactosylated polyethyleneimine on hepatoma cells and mouse liver. Mol Ther, 7, 254–61
   PubMed Web of Science ®Google Scholar
• Mousavi SA, Sporstøl M, Fladeby C, et al. (2007). Receptor-mediated endocytosis of immune complexes in rat liver sinusoidal endothelial cells is mediated by FcγRIIb2. Hepatology, 46, 871–84
   PubMed Web of Science ®Google Scholar
• Multhaupt HA, Gåfvels ME, Kariko K, et al. (1996). Expression of very low density lipoprotein receptor in the vascular wall. Analysis of human tissues by in situ hybridization and immunohistochemistry. Am J Pathol, 148, 1985–97
   Google Scholar
• Nagayama S, Ogawara K, Fukuoka Y, et al. (2007a). Time-dependent changes in opsonin amount associated on nanoparticles alter their hepatic uptake characteristics. Int J Pharm, 342, 215–21
   PubMed Web of Science ®Google Scholar
• Nagayama S, Ogawara K, Minato K, et al. (2007b). Fetuin mediates hepatic uptake of negatively charged nanoparticles via scavenger receptor. Int J Pharm, 329, 192–8
   PubMed Web of Science ®Google Scholar
• Nakai H, Fuess S, Storm TA, et al. (2005). Unrestricted hepatocyte transduction with adeno-associated virus serotype 8 vector in mice. J Virol, 79, 214–24
   PubMed Web of Science ®Google Scholar
• Nathwani AC, Tuddenham EG, Rangarajan S, et al. (2011). Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. N Engl J Med, 365, 2357–65
   PubMed Web of Science ®Google Scholar
• Nishikawa M, Kamijo A, Fujita T, et al. (1993). Synthesis and pharmacokinetics of a new liver-specific carrier, glycosylated carboxymethyl-dextran, and its application to drug targeting. Pharm Res, 10, 1253–61
   PubMed Web of Science ®Google Scholar
• Nishikawa M, Yamauchi M, Morimoto K, et al. (2000). Hepatocyte-targeted in vivo gene expression by intravenous injection of plasmid DNA complexed with synthetic multi-functional gene delivery system. Gene Ther, 7, 548–55
   PubMed Web of Science ®Google Scholar
• Ogawara K, Furumoto K, Nagayama S, et al. (2004). Pre-coating with serum albumin reduces receptor-mediated hepatic disposition of polystyrene nanosphere: implications for rational design of nanoparticles. J Control Release, 100, 451–5
   PubMed Web of Science ®Google Scholar
• Parker AL, Newman C, Briggs S, et al. (2003). Nonviral gene delivery: techniques and implications for molecular medicine. Expert Rev Mol Med, 5, 1–15
   PubMedGoogle Scholar
• Popielarski SR, Hu-Lieskovan S, French SW, et al. (2005). A nanoparticle-based model delivery system to guide the rational design of gene delivery to the liver. 2. In vitro and in vivo uptake results. Bioconjug Chem, 16, 1071–80
   PubMed Web of Science ®Google Scholar
• Praaning-van Dalen DP, de Leeuw AM, Brouwer A, Knook DL. (1987). Rat liver endothelial cells have a greater capacity than Kupffer cells to endocytose N-acetylglucosamine- and mannose-terminated glycoproteins. Hepatology, 7, 672–9
   PubMed Web of Science ®Google Scholar
• Prill JM, Espenlaub S, Samen U, et al. (2011). Modifications of adenovirus hexon allow for either hepatocyte detargeting or targeting with potential evasion from Kupffer cells. Mol Ther, 19, 83–92
   PubMed Web of Science ®Google Scholar
• Rachmawati H, Reker-Smit C, Lub-de Hooge MN, et al. (2007). Chemical modification of interleukin-10 with mannose 6-phosphate groups yields a liver-selective cytokine. Drug Metab Dispos, 35, 814–21
   PubMed Web of Science ®Google Scholar
• Reetz J, Genz B, Meier C, et al. (2013). Development of adenoviral delivery systems to target hepatic stellate cells in vivo. PLoS ONE, 8, e67091
   PubMed Web of Science ®Google Scholar
• Rensen PCN, Sliedregt LAJM, Ferns M, et al. (2001). Determination of the upper size limit for uptake and processing of ligands by the asialoglycoprotein receptor on hepatocytes in vitro and in vivo. J Biol Chem, 276, 37577–84
   PubMed Web of Science ®Google Scholar
• Ryoo SR, Jang H, Kim KS, et al. (2012). Functional delivery of DNAzyme with iron oxide nanoparticles for hepatitis C virus gene knockdown. Biomaterials, 33, 2754–61
   PubMed Web of Science ®Google Scholar
• Sakurai F, Furukawa N, Higuchi M, et al. (2012). Suppression of hepatitis C virus replicon by adenovirus vector-mediated expression of tough decoy RNA against miR-22a. Virus Res, 165, 214–18
   PubMed Web of Science ®Google Scholar
• Sambrano GR, Steinberg D. (1995). Recognition of oxidatively damaged and apoptotic cells by an oxidized low density lipoprotein receptor on mouse peritoneal macrophages: role of membrane phosphatidylserine. Proc Natl Acad Sci USA, 92, 1396–400
   PubMed Web of Science ®Google Scholar
• Sano A, Taylor ME, Leaning MS, Summerfield JA. (1990). Uptake and processing of glycoproteins by isolated rat hepatic endothelial and Kupffer cells. J Hepatol, 10, 211–16
   PubMed Web of Science ®Google Scholar
• Saptarshi SR, Duschl A, Lopata AL. (2013). Interaction of nanoparticles with proteins: relation to bio-reactivity of the nanoparticle. J Nanobiotechnol, 11, 26
   PubMed Web of Science ®Google Scholar
• Schiedner G, Hertel S, Johnston M, et al. (2003). Selective depletion or blockade of Kupffer cells leads to enhanced and prolonged hepatic transgene expression using high-capacity adenoviral vectors. Mol Ther, 7, 35–43
   PubMed Web of Science ®Google Scholar
• Schlaf G, Schieferdecker HL, Rothermel E, et al. (1999). Differential expression of the C5a receptor on the main cell types of rat liver as demonstrated with a novel monoclonal antibody and by C5a anaphylatoxin-induced Ca2+ release. Lab Invest, 79, 1287–97
   PubMed Web of Science ®Google Scholar
• Schwartz AL. (1984). The hepatic asialoglycoprotein receptor. CRC Crit Rev Biochem, 16, 207–33
   PubMed Web of Science ®Google Scholar
• Seki E, Schnabl B. (2012). Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut. J Physiol, 590, 447–58
   PubMed Web of Science ®Google Scholar
• Seymour LW, Ferry DR, Anderson D, et al. (2002). Hepatic drug targeting: phase I evaluation of polymer-bound doxorubicin. J Clin Oncol, 20, 1668–76
   PubMed Web of Science ®Google Scholar
• Shapira A, Shapira S, Gal-Tanamy M, et al. (2012). Removal of hepatitis C virus-infected cells by a zymogenized bacterial toxin. PLoS ONE, 7, e32320
   Google Scholar
• Shashkova EV, Doronin K, Senac JS, Barry MA. (2008). Macrophage depletion combined with anticoagulant therapy increases therapeutic window of systemic treatment with oncolytic adenovirus. Cancer Res, 68, 5896–904
   PubMed Web of Science ®Google Scholar
• Shayakhmetov DM, Gaggar A, Ni S, et al. (2005). Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity. J Virol, 79, 7478–91
   PubMed Web of Science ®Google Scholar
• Shen H, Zhang M, Kaita K, et al. (2005). Expression of Fc fragment receptors of immunoglobulin G (FcγRs) in rat hepatic stellate cells. Dig Dis Sci, 50, 181–7
   PubMed Web of Science ®Google Scholar
• Shimada K, Kamps JAAM, Regts J, et al. (1997). Biodistribution of liposomes containing synthetic galactose-terminated diacylglyceryl-poly(ethyleneglycol)s. Biochim Biophys Acta, 1326, 329–41
   PubMed Web of Science ®Google Scholar
• Shimizu A, Maruta F, Akita N, et al. (2006). Identification of an oligopeptide binding to hepatocellular carcinoma. Oncology, 71, 136–45
   PubMed Web of Science ®Google Scholar
• Skogh T, Blomhoff R, Eskild W, Berg T. (1985). Hepatic uptake of circulating IgG immune complexes. Immunology, 55, 585–94
   PubMed Web of Science ®Google Scholar
• Smedsrød B, De Bleser PJ, Braet F, et al. (1994). Cell biology of liver endothelial and Kupffer cells. Gut, 35, 1509–16
   PubMed Web of Science ®Google Scholar
• Staud F, Nishikawa M, Takakura Y, Hashida M. (1999). Liver uptake and hepato-biliary transfer of galactosylated proteins in rats are determined by the extent of galactosylation. Biochim Biophys Acta, 1427, 183–92
   PubMed Web of Science ®Google Scholar
• Stockert RJ. (1995). The asialoglycoprotein receptor: relationships between structure, function, and expression. Physiol Rev, 75, 591–609
   PubMed Web of Science ®Google Scholar
• Suda T, Suda K, Liu D. (2008). Computer-assisted hydrodynamic gene delivery. Mol Ther, 16, 1098–104
   PubMed Web of Science ®Google Scholar
• Sun-Wada GH, Wada Y, Futai M. (2003). Lysosome and lysosome-related organelles responsible for specialized functions in higher organisms with special emphasis on vacuolar-type proton ATPase. Cell Struct Funct, 28, 455–63
   PubMed Web of Science ®Google Scholar
• Takahashi S, Kawarabayasi Y, Nakai T, et al. (1992). Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor-like protein with distinct ligand specificity. Proc Natl Acad Sci USA, 89, 9252–6
   PubMed Web of Science ®Google Scholar
• Takahashi S, Sakai J, Fujino T, et al. (2004). The very low-density lipoprotein (VLDL) receptor: characterization and functions as a peripheral lipoprotein receptor. J Atheroscler Thromb, 11, 200–8
   PubMedGoogle Scholar
• Takei Y, Maruyama A, Ferdous A, et al. (2004). Targeted gene delivery to sinusoidal endothelial cells: DNA nanoassociate bearing hyaluronan-glycocalyx. FASEB J, 18, 699–701
   PubMed Web of Science ®Google Scholar
• Terpstra V, van Amersfoort ES, van Velzen AG, et al. (2000). Hepatic and extrahepatic scavenger receptors function in relation to disease. Arterioscler Thromb Vasc Biol, 20, 1860–72
   PubMed Web of Science ®Google Scholar
• Terpstra V, van Berkel TJC. (2000). Scavenger receptors on liver Kupffer cells mediate the in vivo uptake of oxidatively damaged red blood cells in mice. Blood, 95, 2175–63
   PubMed Web of Science ®Google Scholar
• Toita R, Kang JH, Tomiyama T, et al. (2012a). Gene carrier showing all-or-none response to cancer cell signaling. J Am Chem Soc, 134, 15410–17
   PubMed Web of Science ®Google Scholar
• Toita R, Murata M, Tabata S, et al. (2012b). Development of human hepatocellular carcinoma cell-targeted protein cages. Bioconjug Chem, 23, 1494–501
   PubMed Web of Science ®Google Scholar
• Tolleshaug H, Berg T, Blomhoff R. (1984). Uptake of mannose-terminated glycoproteins in isolated rat liver cells. Biochem J, 223, 151–60
   PubMed Web of Science ®Google Scholar
• Toth CA, Thomas P. (1992). Liver endocytosis and Kupffer cells. Hepatology, 16, 255–66
   PubMed Web of Science ®Google Scholar
• Un K, Kawakami S, Yoshida M, et al. (2012). Efficient suppression of murine intracellular adhesion molecule-1 using ultrasound-responsive and mannose-modified lipoplexes inhibits acute hepatic inflammation. Hepatology, 56, 259–69
   PubMed Web of Science ®Google Scholar
• van Berkel TJC, De Rijke YB, Kruijt JK. (1991). Different fate in vivo of oxidatively modified low density lipoprotein and acetylated low density lipoprotein in rats. Recognition by various scavenger receptors on Kupffer and endothelial liver cells. J Biol Chem, 266, 2282–9
   PubMed Web of Science ®Google Scholar
• van Beuge MM, Prakash J, Lacombe M, et al. (2011). Reduction of fibrogenesis by selective delivery of a Rho kinase inhibitor to hepatic stellate cells in mice. J Pharmacol Exp Ther, 337, 628–35
   PubMed Web of Science ®Google Scholar
• van Beuge MM, Prakash J, Lacombe M, et al. (2013). Enhanced effectivity of an ALK5-inhibitor after cell-specific delivery to hepatic stellate cells in mice with liver injury. PLoS ONE, 8, e56442
   Google Scholar
• van der Laan-Klamer SM, Atmosoerodjo-Briggs JE, Harms G, et al. (1985). A histochemical study about the involvement of rat liver cells in the uptake of heterologous immune complexes from the circulation. Histochemistry, 82, 477–82
   PubMedGoogle Scholar
• Wang HX, Xiong MH, Wang YC, et al. (2013a). N-acetylgalactosamine functionalized mixed micellar nanoparticles for targeted delivery of siRNA to liver. J Control Release, 166, 106–14
   PubMed Web of Science ®Google Scholar
• Wang W, Li W, Ma N, Steinhoff G. (2013b). Non-viral gene delivery methods. Curr Pharm Biotechnol, 14, 46–60
   PubMed Web of Science ®Google Scholar
• Wang JL, Tang GP, Shen J, et al. (2012a). A gene nanocomplex conjugated with monoclonal antibodies for targeted therapy of hepatocellular carcinoma. Biomaterials, 33, 4597–607
   PubMed Web of Science ®Google Scholar
• Wang L, Su W, Liu Z, et al. (2012b). CD44 antibody-targeted liposomal nanoparticles for molecular imaging and therapy of hepatocellular carcinoma. Biomaterials, 33, 5107–14
   PubMed Web of Science ®Google Scholar
• Wang L, Figueredo J, Calcedo R, et al. (2007). Cross-presentation of adeno-associated virus serotype 2 capsids activates cytotoxic T cells but does not render hepatocytes effective cytolytic targets. Hum Gene Ther, 18, 185–94
   PubMed Web of Science ®Google Scholar
• Weigel JA, Raymond RC, Weigel PH. (2002). The hyaluronan receptor for endocytosis (HARE) is not DC44 or CD54 (ICM-1). Biochem Biophys Res Commun, 294, 918–22
   PubMed Web of Science ®Google Scholar
• Weigel JA, Weigel PH. (2003). Characterization of the recombinant rat 175-kDa hyaluronan receptor for endocytosis (HARE). J Biol Chem, 278, 42802–11
   PubMed Web of Science ®Google Scholar
• Wheeler MD, Yamashina S, Froh M, et al. (2001). Adenoviral gene delivery can inactivate Kupffer cells: role of oxidants in NF-κB activation and cytokine production. J Leukoc Biol, 69, 622–30
   PubMed Web of Science ®Google Scholar
• Wisse E, Braet F, Luo D, et al. (1996). Structure and function of sinusoidal lining cells in the liver. Toxicol Pathol, 24, 100–11
   PubMed Web of Science ®Google Scholar
• Wisse E, De Zanger RB, Charels K, et al. (1985). The liver sieve: considerations concerning the structure and function of endothelial fenestrae, the sinusoidal wall and the space of Disse. Hepatology, 5, 683–92
   PubMed Web of Science ®Google Scholar
• Wong-Staal F, Syder AJ, McKelvy JF. (2010). Targeting HCV entry for development of therapeutics. Viruses, 2, 1718–33
   PubMed Web of Science ®Google Scholar
• Wu GY, Zhan P, Sze LL, et al. (1994). Incorporation of adenovirus into a ligand-based DNA carrier system results in retention of original receptor specificity and enhances targeted gene expression. J Biol Chem, 269, 11542–6
   PubMed Web of Science ®Google Scholar
• Wu J, Liu P, Zhu JL, et al. (1998). Increased liver uptake of liposomes and improved targeting efficacy by labeling with asialofetuin in rodents. Hepatology, 27, 772–8
   PubMed Web of Science ®Google Scholar
• Wu J, Nantz MH, Zern MA. (2002). Targeting hepatocytes for drug and gene delivery: emerging novel approaches and applications. Front Biosci, 7, 717–25
   PubMed Web of Science ®Google Scholar
• Wu L, Yang YF, Ge NJ, et al. (2010). Hepatic arterial iodine-131-labeled metuximab injection combined with chemoembolization for unresectable hepatocellular carcinoma: interim safety and survival data from 110 patients. Cancer Biother Radiopharm, 25, 657–63
   PubMed Web of Science ®Google Scholar
• Xia B, Zhang W, Shi J, Xiao SJ. (2013). Engineered stealth porous silicon nanoparticles via surface encapsulation of bovine serum albumin for prolonging blood circulation in vivo. ACS Appl Mater Interfaces, 5, 11718–24
   PubMed Web of Science ®Google Scholar
• Xiao W, Berta SC, Lu MM, et al. (1998). Adeno-associated virus as a vector for liver-directed gene therapy. J Virol, 72, 10222–6
   PubMed Web of Science ®Google Scholar
• Xiao Y, Zhang H, Zhang Z, et al. (2013). Synthesis of novel tetravalent galactosylated DTPA-DSPE and study on hepatocyte-targeting efficiency in vitro and in vivo. Int J Nanomedcine, 8, 3033–50
   PubMed Web of Science ®Google Scholar
• Xu J, Xu HY, Zhang Q, et al. (2007). HAb18G/ CD147 functions in invasion and metastasis of hepatocellular carcinoma. Mol Cancer Res, 5, 605–14
   PubMed Web of Science ®Google Scholar
• Xu R, Lin F, He J, et al. (2013). Complement 5a stimulates hepatic stellate cells in vitro, and is increased in the plasma of patients with chronic hepatitis B. Immunology, 138, 228–34
   PubMed Web of Science ®Google Scholar
• Yamada T, Iwasaki Y, Tada H, et al. (2003). Nanoparticles for the delivery of genes and drugs to human hepatocytes. Nat Biotechnol, 21, 885–90
   PubMed Web of Science ®Google Scholar
• Yang J, Chen S, Huang L, et al. (2001). Sustained expression of naked plasmid DNA encoding hepatocyte growth factor in mice promotes liver and overall body growth. Hepatology, 33, 848–59
   PubMed Web of Science ®Google Scholar
• Yang N, Ye Z, Li F, Mahato RI. (2009). HPMA polymer-based site-specific delivery of oligonucleotides to hepatic stellate cells. Bioconjug Chem, 20, 213–21
   PubMed Web of Science ®Google Scholar
• Yang PL, Althage A, Chung J, Chisari FV. (2002). Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection. Proc Natl Acad Sci USA, 99, 13825–30
   PubMed Web of Science ®Google Scholar
• Yang X, Haurigot V, Zhou S, et al. (2010). Inhibition of hepatitis C virus replication using adeno-associated virus vector delivery of an exogenous anti-hepatitis C virus microRNA cluster. Hepatology, 52, 1877–87
   PubMed Web of Science ®Google Scholar
• Yokoo T, Kamimura K, Suda T, et al. (2013). Novel electric power-driven hydrodynamic injection system for gene delivery: safety and efficacy of human factor IX delivery in rats. Gene Ther, 20, 816–23
   PubMed Web of Science ®Google Scholar
• Yoshida K, Matsuzaki K. (2012). Differential regulation of TGF-β/Smad signaling in hepatic stellate cells between acute and chronic liver injuries. Front Physiol, 3, Article 53.
   Google Scholar
• Yoshino H, Hashizume K, Kobayashi E. (2006). Naked plasmid DNA transfer to the porcine liver using rapid injection with large volume. Gene Ther, 13, 1696–702
   PubMed Web of Science ®Google Scholar
• Zhang B, Zhang Y, Wang J, et al. (2007a). Screening and identification of a targeting peptide to hepatocarcinoma from a phage display peptide library. Mol Med, 13, 246–54
   PubMed Web of Science ®Google Scholar
• Zhang G, Gao X, Song YK, et al. (2004). Hydroporation as the mechanism of hydrodynamic delivery. Gene Ther, 11, 675–82
   PubMed Web of Science ®Google Scholar
• Zhang G, Vargo D, Budker V, et al. (1997). Expression of naked plasmid DNA injected into the afferent and efferent vessels of rodent and dog livers. Hum Gene Ther, 8, 1763–72
   PubMed Web of Science ®Google Scholar
• Zhang W, Cai R, Luo J, et al. (2007b). The oncolytic adenovirus targeting to TERT and RB pathway induced specific and potent anti-tumor efficacy in vitro and in vivo for hepatocellular carcinoma. Cancer Biol Ther, 6, 1726–32
   PubMed Web of Science ®Google Scholar
• Zhang W, Ke W, Wu SS, et al. (2009). An adenovirus-delivered peptide aptamer C1-1 targeting the core protein of hepatitis B virus inhibits viral DNA replication and production in vitro and in vivo. Peptides, 30, 1816–21
   PubMed Web of Science ®Google Scholar
• Zhang Z, Xu L, Wang Z. (2011). Screening serum biomarkers for early primary hepatocellular carcinoma using a phage display technique. J Clin Lab Anal, 25, 402–8
   PubMed Web of Science ®Google Scholar